{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:32:16Z","timestamp":1770427936850,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ijantimicag.2003.07.003","type":"journal-article","created":{"date-parts":[[2004,1,17]],"date-time":"2004-01-17T10:15:06Z","timestamp":1074334506000},"page":"155-163","source":"Crossref","is-referenced-by-count":23,"title":["Bacteraemia in Europe\u2014antimicrobial susceptibility data from the MYSTIC surveillance programme"],"prefix":"10.1016","volume":"23","author":[{"given":"Serhat","family":"Unal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Masterton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.271.20.1598","article-title":"Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality","volume":"271","author":"Pittet","year":"1994","journal-title":"JAMA"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2003.07.003_BIB2","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1086\/314078","article-title":"Nosocomial bloodstream infections: organisms, risk factors, and implications","volume":"31","author":"Karchmer","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/clinids\/24.3.387","article-title":"Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC)","volume":"24","author":"Valles","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00003246-199908000-00002","article-title":"A 25-year study of nosocomial bacteremia in an adult intensive care unit","volume":"27","author":"Edgeworth","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0924-8579(99)00115-6","article-title":"The MYSTIC (meropenem yearly susceptibility test information collection) programme","volume":"13","author":"Turner","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.274.8.639","article-title":"The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee","volume":"274","author":"Vincent","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a 3-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10096-001-8078-8","article-title":"Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997\u20131998","volume":"20","author":"Fluit","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0732-8893(01)00320-0","article-title":"MYSTIC program: summary of European data from 1997 to 2000","volume":"41","author":"Goossens","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s100960100455","article-title":"Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients","volume":"20","author":"Fluit","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0924-8579(99)00131-4","article-title":"Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group","volume":"13","author":"Diekema","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl. T2","key":"10.1016\/j.ijantimicag.2003.07.003_BIB13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/46.suppl_2.9","article-title":"MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview","volume":"46","author":"Turner","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB14","unstructured":"NCCLS. Performance standard for microbial susceptibility testing. Wayne, PA; 2002. p. M100-S12."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB15","doi-asserted-by":"crossref","first-page":"2S17","DOI":"10.1111\/j.1469-0691.1999.tb00538.x","article-title":"Bacteremia caused by multi-resistant Gram-positive microorganisms","volume":"5","author":"Spencer","year":"1999","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl. D","key":"10.1016\/j.ijantimicag.2003.07.003_BIB16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/41.suppl_4.7","article-title":"The changing pattern of infection in neutropenic patients","volume":"41","author":"Oppenheim","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB17","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(96)00102-7","article-title":"Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients","volume":"100","author":"Jones","year":"1996","journal-title":"Am. J. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2003.07.003_BIB18","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1378\/chest.115.suppl_1.3S","article-title":"Overview of resistance in the 1990s","volume":"115","author":"File","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00003495-200059030-00016","article-title":"Meropenem: a review of its use in patients in intensive care","volume":"59","author":"Hurst","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2165\/00003495-200060030-00010","article-title":"Meropenem: an updated review of its use in the management of intra- abdominal infections","volume":"60","author":"Lowe","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1469-0691.2000.00082.x","article-title":"Meropenem versus imipenem\/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit","volume":"6","author":"Verwaest","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1179\/joc.2001.13.1.70","article-title":"Serious Infection Study Group. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia","volume":"13","author":"Alvarez-Lerma","year":"2001","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0195-6701(95)90209-0","article-title":"Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong Kong","volume":"31","author":"Ho","year":"1995","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0732-8893(01)00321-2","article-title":"Unit differences in pathogen occurrence arising from the MYSTIC program European database (1997\u20132000)","volume":"41","author":"Mendes","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jac\/47.6.789","article-title":"Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test","volume":"47","author":"Henwood","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/srin.2000.20934","article-title":"Extended-spectrum beta-lactamases","volume":"15","author":"Patterson","year":"2000","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.ijantimicag.2003.07.003_BIB27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2257.2001.00347.x","article-title":"Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan","volume":"23","author":"Zaidi","year":"2001","journal-title":"Clin. Lab. Haematol."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T14:53:35Z","timestamp":1550242415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903003777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0924857903003777"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.07.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}